Psychotropic Agents

Part III: Alcohol and Psychotomimetics, Psychotropic Effects of Central Acting Drugs

  • F. Hoffmeister
  • G. Stille

Part of the Handbook of Experimental Pharmacology book series (HEP, volume 55 / 3)

Table of contents

  1. Front Matter
    Pages I-XXVI
  2. Psychotomimetics

    1. Front Matter
      Pages 1-1
    2. A. T. Shulgin
      Pages 3-29
    3. J. B. Appel, A. D. Poling, D. M. Kuhn
      Pages 45-55
    4. D. X. Freedman, W. O. Boggan
      Pages 57-88
    5. G. K. Aghajanian
      Pages 89-109
  3. Cannabis

    1. Front Matter
      Pages 117-117
    2. R. Mechoulam
      Pages 119-134
  4. Alcohol

    1. Front Matter
      Pages 159-159
    2. T. L. Chruściel
      Pages 161-176
    3. N. K. Mello
      Pages 177-208
    4. J. Ellingboe, J. H. Mendelson
      Pages 209-237
  5. Psychotropic Effects of Central Acting Drugs

    1. Front Matter
      Pages 267-267
    2. S. R. Goldberg, R. D. Spealman, H. E. Shannon
      Pages 269-304
    3. W. R. Martin
      Pages 305-329
    4. L. G. Abood
      Pages 331-347
    5. D. A. Buxton, D. T. Greenwood, D. N. Middlemiss
      Pages 349-367
    6. C.-J. Estler
      Pages 369-389
    7. H. Heimann, H. J. Gaertner
      Pages 391-407
  6. Back Matter
    Pages 425-510

About this book


The description of the pharmacology of psychotomimetics, cannabis, and alcohol in this third volume concludes the discussion on psychotropic agents. As psychomotor stimulants these groups of psychotropic agents are of little or no therapeutic relevance, but since they are used in a nonmedical manner, or are even considered by some groups of the population as social commodities, their behavioral effects and psychopharmacological properties are not the concern of the pharmacol­ ogist alone. The same is true of psychotomimetics, as well as cannabis and its components. Psychotomimetics have a social history going back many hundreds of years and are among the most potent psychotropic agents known to man. The closing description of psychopharmacology also deals with the psychotropic effects of a number of drugs not primarily considered to be psychotropic. Their psychotropic effects are either an inherent constituent of their therapeutic profile, as is the case with opiates, hypnotics, and caffeine, or they may occur indirectly as side effects or accompanying effects during therapy. This applies to p-adrenoreceptor antagonists and anticholinergics. The editors are also aware that a description of psychotropic agents would not have been complete without discussing the medical, ethical, and legal aspects of the development, clinical testing, and use of such drugs.


Acetylcholin Aldehyde Alkohol Rauschgift Serotonin alcohol analgesics cannabinoid chemistry neurotransmitter pharmacodynamics pharmacokinetics pharmacology research toxicology

Editors and affiliations

  • F. Hoffmeister
    • 1
  • G. Stille
    • 2
  1. 1.Institut für PharmakologieBayer AGWuppertal 1Germany
  2. 2.Institut für Arzneimittel des BundesgesundheitsamtesBerlin 30Germany

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag Berlin Heidelberg 1982
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-642-67772-4
  • Online ISBN 978-3-642-67770-0
  • Series Print ISSN 0171-2004
  • Series Online ISSN 1865-0325
  • Buy this book on publisher's site